Skip to main content
Erschienen in: American Journal of Clinical Dermatology 6/2009

01.12.2009 | Short Communication

Impact of Psoriasis on Patients’ Work and Productivity

A Retrospective, Matched Case-Control Analysis

verfasst von: Ying Wu, Douglas Mills, Mohan Bala

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 6/2009

Einloggen, um Zugang zu erhalten

Abstract

Background: Psoriasis negatively impacts patient quality of life; however, the impact on work and productivity is not well known.
Objective: To determine the impact of psoriasis on work and productivity using data from the National Health and Wellness Survey (NHWS).
Methods: Data collected from 40 730 adults who completed the NHWS between 1 May and 30 June 2004, of whom 1127 had psoriasis, were analyzed. Psoriasis patients and a matched cohort of non-psoriasis patients were identified to assess the impact of psoriasis on work and productivity.
Results: Psoriasis patients were more likely to have missed work for health-related reasons (p < 0.05), had significantly more health-related work productivity impairment (p < 0.001), more overall work impairment (p < 0.001), and more impairment in activity other than work (p < 0.001) than non-psoriasis patients.
Conclusions: The results of this large-scale national survey suggest that psoriasis has a significant negative impact on overall work productivity.
Literatur
1.
3.
Zurück zum Zitat Feldman SR, Fleischer AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997 Oct; 37 (4): 564–9PubMedCrossRef Feldman SR, Fleischer AB, Reboussin DM, et al. The economic impact of psoriasis increases with psoriasis severity. J Am Acad Dermatol 1997 Oct; 37 (4): 564–9PubMedCrossRef
6.
Zurück zum Zitat Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6 (6): 383–92PubMedCrossRef Kimball AB, Jacobson C, Weiss S, et al. The psychosocial burden of psoriasis. Am J Clin Dermatol 2005; 6 (6): 383–92PubMedCrossRef
7.
Zurück zum Zitat Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005 Mar; 64 Suppl. 2: ii 18–23 Langley RG, Krueger GG, Griffiths CE. Psoriasis: epidemiology, clinical features, and quality of life. Ann Rheum Dis 2005 Mar; 64 Suppl. 2: ii 18–23
8.
Zurück zum Zitat Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001 Mar; 137 (3): 280–4PubMed Krueger G, Koo J, Lebwohl M, et al. The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermatol 2001 Mar; 137 (3): 280–4PubMed
9.
Zurück zum Zitat Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995 Feb; 132 (2): 236–44PubMedCrossRef Finlay AY, Coles EC. The effect of severe psoriasis on the quality of life of 369 patients. Br J Dermatol 1995 Feb; 132 (2): 236–44PubMedCrossRef
10.
Zurück zum Zitat Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a Work Productivity and Activity Impairment instrument. Pharmacoeconomics 1993 Nov; 4 (5): 353–65PubMedCrossRef Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a Work Productivity and Activity Impairment instrument. Pharmacoeconomics 1993 Nov; 4 (5): 353–65PubMedCrossRef
11.
Zurück zum Zitat Ware JE, Kosinski M, Dewey JE, et al. How to score and interpret single-item health status measures: a manual for users of the SF-8 Health Survey. Lincoln (RI): Quality Metric Incorporated, 2001 Ware JE, Kosinski M, Dewey JE, et al. How to score and interpret single-item health status measures: a manual for users of the SF-8 Health Survey. Lincoln (RI): Quality Metric Incorporated, 2001
13.
Zurück zum Zitat Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999 Sep; 41 (3 Pt 1): 401–7PubMedCrossRef Rapp SR, Feldman SR, Exum ML, et al. Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999 Sep; 41 (3 Pt 1): 401–7PubMedCrossRef
14.
Zurück zum Zitat Fortune DG, Richards HL, Main CJ, et al. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998 Aug; 39 (2 Pt 1): 196–201PubMedCrossRef Fortune DG, Richards HL, Main CJ, et al. What patients with psoriasis believe about their condition. J Am Acad Dermatol 1998 Aug; 39 (2 Pt 1): 196–201PubMedCrossRef
15.
Zurück zum Zitat Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003; 4 (12): 833–42PubMedCrossRef Gupta MA, Gupta AK. Psychiatric and psychological co-morbidity in patients with dermatologic disorders: epidemiology and management. Am J Clin Dermatol 2003; 4 (12): 833–42PubMedCrossRef
16.
Zurück zum Zitat Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995 May; 75 (3): 240–3PubMed Gupta MA, Gupta AK. The Psoriasis Life Stress Inventory: a preliminary index of psoriasis-related stress. Acta Derm Venereol 1995 May; 75 (3): 240–3PubMed
17.
Zurück zum Zitat Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994 Jan-Feb; 56 (1): 36–40PubMed Gupta MA, Gupta AK, Schork NJ, et al. Depression modulates pruritus perception: a study of pruritus in psoriasis, atopic dermatitis, and chronic idiopathic urticaria. Psychosom Med 1994 Jan-Feb; 56 (1): 36–40PubMed
18.
Zurück zum Zitat Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002 Feb; 12 (2): 250–61PubMedCrossRef Wahl AK, Gjengedal E, Hanestad BR. The bodily suffering of living with severe psoriasis: in depth interviews with 22 hospitalized patients with psoriasis. Qual Health Res 2002 Feb; 12 (2): 250–61PubMedCrossRef
19.
Zurück zum Zitat Pearce DJ, Singh S, Balkrishnan R, et al. The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006 Feb; 17 (1): 24–8PubMedCrossRef Pearce DJ, Singh S, Balkrishnan R, et al. The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006 Feb; 17 (1): 24–8PubMedCrossRef
20.
Zurück zum Zitat Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006 Aug; 213 (2): 102–10PubMedCrossRef Schmitt JM, Ford DE. Work limitations and productivity loss are associated with health-related quality of life but not with clinical severity in patients with psoriasis. Dermatology 2006 Aug; 213 (2): 102–10PubMedCrossRef
Metadaten
Titel
Impact of Psoriasis on Patients’ Work and Productivity
A Retrospective, Matched Case-Control Analysis
verfasst von
Ying Wu
Douglas Mills
Mohan Bala
Publikationsdatum
01.12.2009
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 6/2009
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/11310440-000000000-00000

Weitere Artikel der Ausgabe 6/2009

American Journal of Clinical Dermatology 6/2009 Zur Ausgabe

Acknowledgments

Acknowledgment

Therapy In Practice

Ichthyosis

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Studienlage spricht für Isotretinoin zur Rosazea-Therapie

23.05.2024 Rosazea Nachrichten

Isotretinoin wird off-label zur Behandlung von Rosazea eingesetzt. Wie solide die Evidenz dafür ist, wurde jetzt in einem systematischen Review überprüft.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Riesenzellarteriitis: 15% der Patienten sind von okkulter Form betroffen

16.05.2024 Riesenzellarteriitis Nachrichten

In einer retrospektiven Untersuchung haben Forschende aus Belgien und den Niederlanden die okkulte Form der Riesenzellarteriitis genauer unter die Lupe genommen. In puncto Therapie und Rezidivraten stellten sie keinen sehr großen Unterschied zu Erkrankten mit kranialen Symptomen fest.

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.